English
Spanish
French
Italian
German
NEWS
Latest News
Expert Insights on HS: What Every Patient Should Know About Today’s Treatment Landscape
Yesterday
In a new episode of the Derms on Drugs podcast, leading dermatology experts discuss the evolving understanding of hidradenitis suppurativa, including treatment strategies, emerging therapies, and what real progress looks like for patients. Tune in to hear practical insights that shed light on where HS care is headed and how it continues to change lives.
Read more
A New Era of Hope for HS: Personalized Treatments Are Changing the Outlook
March 31, 2026
What if HS care could be tailored to you? At the 2026 AAD Annual Meeting, dermatology experts shared how personalized combinations of medical and in‑office surgical treatments are improving outcomes and bringing new hope to people living with moderate to severe hidradenitis suppurativa. Learn how these advances could shape the future of HS care and why they matter now.
Read more
Raising the Bar for HS Outcomes With Barry Resnik, MD
March 15, 2026
Years-long diagnostic delays and incremental treatment approaches have left many patients struggling. Barry Resnik shares how earlier escalation, clearer treatment goals, and a focus on function, not just lesions, could change the trajectory of hidradenitis suppurativa care.
Read more
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
March 5, 2026
A team of dermatology experts has just agreed on a standardized way to identify and classify HS lesions, potentially transforming how clinical trials measure disease and evaluate treatments. Find out how this new consensus could reshape research and bring us closer to better therapies.
Read more
Understanding Moderate Hidradenitis Suppurativa: Diagnosis, Impact, and Treatment
February 25, 2026
Explore why early recognition and tailored care are vital for patients with moderate hidradenitis suppurativa. This Dermatology Times piece breaks down key challenges in diagnosis, the real impact on quality of life, and evolving treatment strategies, including when to consider systemic and biologic therapies to prevent disease progression.
Read more
“I Lost 15 Years of My Life”: A Man’s Journey With Hidradenitis Suppurativa
February 25, 2026
In a revealing interview conducted by The Educated Patient, Keven Brown opens up about his long, painful battle with hidradenitis suppurativa — from years of misdiagnosis and physical hardship to the emotional toll of living with a chronic condition and the resilience it took to reclaim his life.
Read more
Do GLP-1 medications help signs and symptoms of Hidradenitis Suppurativa?
February 23, 2026
Could a medication commonly used for type 2 diabetes and weight loss also help improve hidradenitis suppurativa? New research explores the potential impact of GLP-1 receptor agonists on HS signs, symptoms, and quality of life. Click to learn what researchers found and what it could mean for people living with HS.
Read more
Hidradenitis Suppurativa in Patients with Skin of Color: Emerging Therapies and Strategies for Effective Management
January 22, 2026
New insights highlight emerging therapies and practical strategies for managing hidradenitis suppurativa in patients with skin of color. Learn how evolving treatments, improved diagnostic approaches, and patient-centered care are reshaping HS management and addressing long-standing gaps in care.
Read more
Timing, Severity, and Therapeutic Choice in Moderate to Severe HS
January 14, 2026
When should HS treatment escalate? This case-based discussion with HS Foundation board member, Dr. Afsaneh Alavi, explores how timing, severity assessment, and therapeutic choice shape outcomes in moderate to severe hidradenitis suppurativa.
Read more
Beyond the Surface: January 2026
January 13, 2026
Catch the latest from the Hidradenitis Suppurativa Foundation — explore new HS insights, updated wound care resources, SHSA 2026 details, and apply for the Mentored Experience Grant by January 31.
Read more